CODX
Co-Diagnostics, Inc. Common Stock
stockNASDAQ
co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.38 | 2026-11-03 | -15.80% | 5.845 |
| 1M | 1.12 | 2026-10-09 | -71.43% | 5.733 |
| 3M | 1.50 | 2026-08-10 | -78.67% | 4.895 |
| 6M | 1.90 | 2026-05-11 | -83.16% | 3.478 |
| 1Y | 11.71 | 2025-11-10 | -97.27% | 2.260 |
| 2Y | 35.40 | 2024-11-11 | -99.10% | — |
| 5Y | 259.20 | 2021-11-10 | -99.88% | 1.572 |
Co-Diagnostics, Inc. Common Stock (NASDAQ:CODX) stock price today is $0.32, and today's volume is 24,151,910. CODX is up 24.591% today. The 30 day average volume is 1.25M. CODX market cap is $2.82M with 8.82M shares outstanding.